XIN-6301

N/A

Report date: 2023/07/07 17:35:33
NME

Base Information

Drug NameXIN-6301
Drug Alias NameXIN-6301
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsBrain Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXinThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesXinThera Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsBrain Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A